Kineret Solution For Injection 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Kineret: Solution for injection (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ANAKINRA (an a KIN ra) is used to treat rheumatoid arthritis and Neonatal-Onset Multisystem Inflammatory Disease (NOMID).

In-Depth Information
Select a Medication

Kineret 100mg/0.67ml Solution for Injection

NDC: 555130177
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Rheumatoid Arthritis, Cryopyrin-associated Periodic Syndromes (CAPS)

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Do not freeze
Kineret 100mg/0.67ml Solution for Injection

Reported Side Effects for Kineret 100mg/0.67ml Solution for Injection

Secondary Malignancy Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
<12.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
<11.6%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
0.4-4.7%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
12.0-14.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
14.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
16.3-71.0%*
Severity: MILD
Onset: RAPID
Infection Incidence:
39.0%*
Severity: MILD
Onset: DELAYED
Antibody Formation Incidence:
49.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Kineret

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5